Cathie Wood's ARK ETF published their daily trades for Thursday, December 12th, 2024, revealing a series of strategic moves within its portfolio. Topping the list in terms of dollar value, ARK's ARKK ETF sold 51,335 shares of Tesla Inc (NASDAQ:TSLA), amounting to a significant $21,805,567. This sale stands out as the most substantial trade of the day, reflecting ARK's latest adjustment in its position on the electric vehicle giant.
On the flip side, ARK showed a growing interest in Tempus AI Inc (TEM), with a combined purchase of 424,522 shares across its ARKK and ARKG ETFs, totaling $18,335,104. This move indicates a bullish stance on the artificial intelligence company and marks a continuation of ARK's investment in the firm, following similar acquisitions earlier in the week.
ARK also made a notable sale of 205,897 shares of Rocket Lab USA Inc (NASDAQ:RKLB) through its ARKQ ETF, totaling $4,807,695. This sell-off was closely followed by a purchase in the same ETF, acquiring 154,873 shares of Symbotic Inc (NASDAQ:SYM) for $4,132,011, reflecting a rebalancing towards the robotics automation company.
Other sales included Adaptive Biotechnologies Corp (NASDAQ:ADPT) with 20,353 shares sold for $129,852, Veracyte Inc (NASDAQ:VCYT) shedding 31,181 shares at $1,356,685, and Veeva Systems Inc (NYSE:NYSE:VEEV) with a sale of 4,660 shares valued at $1,089,741. These trades, although smaller in scale compared to the Tesla and Rocket Lab transactions, are part of ARK's daily portfolio management.
Senti Biosciences Inc (NASDAQ:SNTI) also saw a minor reduction, with 163 shares sold for a modest $893. This follows a pattern of selling the biotech stock throughout the previous week.
Investors and market analysts closely monitor ARK's daily trades for insights into Cathie Wood's investment strategy. The consistent buying of Tempus AI Inc shares suggests a growing confidence in the company's prospects, while the divestment from Tesla could signal a strategic shift or a simple cashing in on recent gains.
As ARK continues to adapt its ETF portfolios, investors will be keen to see how these daily trades align with broader market trends and the investment firm's long-term vision.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.